4//SEC Filing
HANNA NABIL 4
Accession 0001209191-04-008262
CIK 0000875045other
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 3:47 PM ET
Size
7.3 KB
Accession
0001209191-04-008262
Insider Transaction Report
Form 4
BIOGEN IDEC INCBIIB
HANNA NABIL
Chief Scientific OfficerOther
Transactions
- Award
Common Stock
2004-02-06+10,990→ 444,625 total - Award
NQ Stock Option (right to buy)
2004-02-06+32,970→ 32,970 totalExercise: $43.50Exp: 2014-02-06→ Common Stock (32,970 underlying)
Footnotes (3)
- [F1]Restricted stock which fully vests on the third anniversary of the grant date of 02/06/2004.
- [F2]The stock option becomes exercisable in four (4) equal annual installments on 12/31/04, 12/31/05, 12/31/06 and 12/31/07.
- [F3]Granted under Issuer's 2003 Omnibus Equity Plan, in an exempt transaction under SEC rule 16b-3(d).
Documents
Issuer
BIOGEN IDEC INC
CIK 0000875045
Entity typeother
Related Parties
1- filerCIK 0001236543
Filing Metadata
- Form type
- 4
- Filed
- Feb 9, 7:00 PM ET
- Accepted
- Feb 10, 3:47 PM ET
- Size
- 7.3 KB